New HIV drug GS-3242 enters early human testing

NCT ID NCT07001319

Recruiting now Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 34 times

Summary

This early-stage study tests a new experimental HIV medicine, GS-3242, in 30 people living with HIV-1. The goal is to see how safe it is, how the body processes it, and how well it lowers the amount of virus in the blood over 11 days. Participants must have a certain level of virus and not have taken HIV drugs recently.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AIDS Healthcare Foundation - Northpoint
RECRUITING

Fort Lauderdale, Florida, 33308, United States
AXCES Research Group, LLC
RECRUITING

El Paso, Texas, 79902, United States
AXCES Research Group, LLC
RECRUITING

Salt Lake City, Utah, 84102, United States
BLISS Health
RECRUITING

Orlando, Florida, 32803, United States
Bamrasnaradura Infectious Diseases Institute
RECRUITING

Nonthaburi, 11000, Thailand
Be Well Medical Center
RECRUITING

Berkley, Michigan, 48072, United States
Central Texas Clinical Research
RECRUITING

Austin, Texas, 78705, United States
Chatham County Health Department
RECRUITING

Savannah, Georgia, 31401, United States
Faculty of Medicine Ramathibodi Hospital, Mahidol University
RECRUITING

Bangkok, 10400, Thailand
Faculty of Medicine Siriraj Hospital, Mahidol University
RECRUITING

Bangkok, 10700, Thailand
Franco Felizarta, MD
RECRUITING

Bakersfield, California, 93301, United States
Indiana University School of Medicine
RECRUITING

Indianapolis, Indiana, 46202, United States
Institute of HIV Research and Innovation (IHRI)
RECRUITING

Bangkok, 10330, Thailand
KC CARE Health Center
RECRUITING

Kansas City, Missouri, 64111, United States
Midland Florida Clinical Research Center, LLC
RECRUITING

DeLand, Florida, 32720, United States
Midway Immunology & Research Center, LLC
RECRUITING

Ft. Pierce, Florida, 34982, United States
Mills Clinical Research
RECRUITING

Los Angeles, California, 90069, United States
North Texas Infectious Diseases Consultant's, P.A.
RECRUITING

Dallas, Texas, 75246, United States
Orlando Immunology Center, PA
RECRUITING

Orlando, Florida, 32803, United States
Prism Health North Texas
RECRUITING

Dallas, Texas, 75208, United States
ProcliniQ Investigación Clínica S.A. de C.V
RECRUITING

Mexico City, 6170, Mexico
Quest Clinical Research
RECRUITING

San Francisco, California, 94115, United States
Ruane Clinical Research Group, Inc
RECRUITING

Los Angeles, California, 90036, United States
Srinagarind Hospital, Faculty of Medicine, Khon Kaen University
RECRUITING

Khon Kaen, 40002, Thailand
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),Thai Red Cross AIDS and Infectious Disease Research Center
RECRUITING

Pathumwan, 10330, Thailand
Triple O Research Institute, P.A.
RECRUITING

West Palm Beach, Florida, 33407, United States
University of Cincinnati College of Medicine
RECRUITING

Cincinnati, Ohio, 45267, United States
Washington Health Institute
RECRUITING

Washington D.C., District of Columbia, 20017, United States

Conditions

Explore the condition pages connected to this study.

HIV-1 INFECTION